Recombinant Mouse Lymphotoxin alpha2/beta1 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 1008-LY/CF
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Leu34-Leu202 (LT alpha) & Gly136-Gly306 (LT beta)
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 10-40 ng/mL.
Formulation, Preparation and Storage
1008-LY/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Lymphotoxin
Lymphotoxin-alpha (LT alpha), also known as tumor necrosis factor (TNF) beta, and lymphotoxin-beta (LT beta) are members of the TNF family. LT alpha cDNA encodes a 202 amino acid secreted soluble protein with a 33 amino acid signal sequence. LT beta cDNA encodes a 306 amino acid type II membrane protein with an N-terminal cytoplasmic domain (residues 1 - 18), a transmembrane region (residues 29 - 48), and an extracellular domain (residues 49 - 306). Secreted LT alpha assembles as a soluble homotrimer, LT alpha3. In addition, secreted LT alpha also complexes with the membrane associated LT beta to generate two types of heterotrimers, LT alpha1/ beta2 and LT alpha2/ beta1 (1). The soluble LT alpha3 binds both TNF RI (p55) and TNF RII (p75). In contrast, the predominant membrane-bound heterotrimer, LT alpha1/ beta2, binds only to the lymphotoxin beta receptor (LT betaR). LT alpha2/ beta1 is capable of binding LT betaR, TNF RI (p55), and TNF RII (p75). LT plays a role in normal lymphoid organogenesis (2, 3). Transgenic LT alpha knock-out mice exhibited a loss in lymph node development, a change in splenic architecture, and impaired germinal center formation (4). LT is expressed by activated naïve CD4 cells, unpolarized IL-2-secreting effectors, and Th1 effectors. A loss of LT expression and lack of TNF-alpha or TNF-beta secretion is associated with prior exposure to IL-4 and a Th2 phenotype (5).
References
- Browning et al. (1993) Cell 72:847.
- Ettinger et al. (1996) Proc. Natl. Acad. Sci. USA 93:13102.
- Cuff et al. (1998) J. Immunol. 161:6853.
- Browning et al. (1997) J. Immunol. 159:3288.
- Gramaglia et al. (1999) J. Immunol. 162:1333.
Alternate Names
Gene Symbol
Additional Lymphotoxin Products
Product Documents for Recombinant Mouse Lymphotoxin alpha2/beta1 Protein, CF
Product Specific Notices for Recombinant Mouse Lymphotoxin alpha2/beta1 Protein, CF
For research use only